CLL Cells from Ibrutinib-Induced Lymphocytosis of Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Are Responsive to Obinutuzumab, but Not Rituximab, Ex Vivo - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Blood Année : 2015

CLL Cells from Ibrutinib-Induced Lymphocytosis of Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Are Responsive to Obinutuzumab, but Not Rituximab, Ex Vivo

Domaines

Cancer Immunologie
Fichier non déposé

Dates et versions

hal-02348727 , version 1 (05-11-2019)

Identifiants

Citer

Loic Ysebaert, Christian Klein, Anne Quillet-Mary. CLL Cells from Ibrutinib-Induced Lymphocytosis of Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Are Responsive to Obinutuzumab, but Not Rituximab, Ex Vivo. Blood, 2015, 126 (23), pp.4157-4157. ⟨10.1182/blood.V126.23.4157.4157⟩. ⟨hal-02348727⟩
22 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More